Funding
Chemical ARX degraders
Stefan Kubicek
Breakthrough FY24 Innovative Award (INO)
Duration 2024 - 2026
CD Laboratory for Chemical Epigenetics and Antiinfectives
Translating Tudor domain splicing inhibitors for oncological applications
Point of Contact: Pinpointing Small Molecule-Protein Binding
Visual Proteomics for studying subcellular protein dynamics
Nuclear One Carbon Metabolism
StrikeBC - Multimodal Strategies to Target Key Challenges in Bladder Cancer
Christoph Bock / Stefan Kubicek
LBG Clinical Research Group
Duration 2026 - 2029
Innovative chemistry library to probe biology
Mechanistic target elucidation by systematic stochastic tagging of antiproliferative compounds